Skip to content
People

Carlo Rizzuto

Director at Nexo Therapeutics.

Earliest Form D on file: Mar 2026

Filed Mar 27, 2026Amendment

Nexo Therapeutics

Covalent drugs for cancer targets without binding pockets

Biotech, Littleton CO

Named, Director.

$60M

sold of $60M offered

Form D

Reported on an amendment to an earlier filing.

Network

At Nexo Therapeutics

2 people